The Microbes Behind Psoriasis: A New View

Psoriasis is a chronic skin disorder driven by genetics, the immune system, and environmental factors. Recent research highlights that changes in our gut and skin bacteria are not mere side notes—they may be key drivers of the disease.

How Microbes Fuel Inflammation

• Disturbed gut microbiome
• Weakens the intestinal wall.
• Lowers short‑chain fatty acids (SCFAs), essential protective chemicals.

• Pushes the immune system toward a harmful Th17 response.

• Skin microbiome imbalance
• Overgrowth of Staphylococcus aureus and fungal shifts compromise the skin barrier.
• The body’s reaction to these microbes fuels a cycle of IL‑17 inflammation, worsening the rash.

Together, gut and skin microbes form a feedback loop that keeps psoriasis active.

Infection Triggers

Certain infections tap into the same immune pathways:

• Hepatitis C virus
• Helicobacter pylori (stomach bacteria)
• Streptococci

These infections can spark flares by activating the shared immune routes used by gut and skin microbes.

Current Treatments & Risks

• Biologics (immune‑targeting drugs)
• Can remodel the microbiome alongside symptom relief.

• Increase infection risk, requiring careful monitoring.

• Probiotics
• Early studies show promise, but results are inconsistent due to heterogeneous study designs.

The Path Forward

Scientists must demonstrate causation, not just correlation, by:

1. Combining genetic data with microbiome profiles.
2. Conducting functional tests to observe how microbes alter immune signaling.

The ultimate goal: personalized care that restores the gut‑skin axis and reduces psoriasis flares.